Choosing the Right Digital Technologies with Patients in Mind

Jakob Alme joined Sage Therapeutics in 2021. As the Head of Digital Health, he is focused on rethinking care and how it is delivered to help patients and families impacted by brain health disorders. In this role, he leads the function’s efforts in implementing digital health strategies across the organization, ranging from preclinical and translational through development, commercialization, and on-market planning. Prior to his time at Sage, Mr Alme led the digital health asset design for immunology at AbbVie, and also held roles in clinical operations, compliance, and data sciences. He holds a BS in Health and Human Performance from the University of Montana.